Company Adorbs Inc.

ADOB

US00726D1046

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

Adorbs Inc. is a developmental stage company. The Company is engaged in creation and commercialization of children's clothing with organic materials. The Company offers children's clothes such as leggings, t-shirt, sweatshirts, skirts, dresses, and onesies. The Company's clothing has basic bold colors, such as black, red, orange, yellow, green, grey, blue, purple, and fuchsia. It includes a variety of ideas with patch work, applique, food, emojis, animals, letters, and words. The Company sells products through its Website and buyer can choose size with a scroll bar, and choose the applique design.

Number of employees: 2

USD in Million	2021	Weight	2022	Weight	Delta
Organic Children's Clothing 100.0 %	0	100.0 %	0	100.0 %	+366,069.14%

USD in Million	2021	Weight	2022	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	+366,069.14%

Managers	Title	Age	Since
Rachel Martinuik CEO	Chief Executive Officer	48	23-03-12
Nichol Martinuik CHM	Chairman	49	23-03-12

Members of the board	Title	Age	Since
Rachel Martinuik CEO	Chief Executive Officer	48	23-03-12
Nichol Martinuik CHM	Chairman	49	23-03-12

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	598,545,644	75,545,644 ( 12.62 %)	0	12.62 %

Name	Equities	%	Valuation
102162963 Saskatchewan Ltd. 60.15 %	360,000,000	60.15 %	720 M $
Ismail Abdul Fattah 11.53 %	69,000,000	11.53 %	138 M $
David Lazar 8.187 %	49,000,000	8.187 %	98 M $
Bailey Fischl 7.518 %	45,000,000	7.518 %	90 M $

Adorbs, Inc.

36 Fourth Avenue North

S3N 2V7, Yorkton

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+34.35%	705B
NOVO NORDISK A/S	+30.74%	583B
JOHNSON & JOHNSON	-3.49%	364B
MERCK & CO., INC.	+20.15%	332B
ABBVIE INC.	+6.19%	291B
ASTRAZENECA PLC	+15.75%	238B
ROCHE HOLDING AG	-3.48%	210B
NOVARTIS AG	+10.40%	209B
AMGEN INC.	+9.21%	169B

Other Pharmaceuticals